Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

JM selling property in Tønsberg

JM has signed an agreement for the sale of a property located in Tønsberg, in Vestfold county. The transaction amounts to approximately SEK 47m.The property being sold consists of undeveloped industrial land previously assessed to have potential for residential development corresponding to approximately 11,000 square meters of living space. The sales price amounts to approximately SEK 47m, which provides a profit from property sales of approximately SEK 7m. The transaction will be reported in the third quarter of 2024 within the business segment JM Norway. Partial payment is received in

Gaming Innovation Group: Invitation to Q2 2024 results presentation

Gaming Innovation Group Inc. (GiG) publishes its interim report for the second quarter 2024 before market opening on Wednesday 28 August 2024. Chairman of the Board, Mikael Riese Harstad, will host a presentation of the Q2 2024 results via livestream at 10:00 CET with Jonas Warrer, CEO Media and group CEO, and Richard Carter, CEO Platform & Sportsbook, attending. The presentation will be followed by a Q&A-session, and investors, analysts and journalists are welcome to participate. The presentation will be given in English. Link to the livestream:https://www.redeye.se/events/1026774/

Monivent signs a Letter of Intent (LOI) to enter a global distribution agreement with a major industry leading player

A defining step towards a commercial breakthrough for Monivent’s innovative product (Neo100), supporting a gentle and effective ventilation of newborns, is a strong collaboration with an industry partner with global commercial reach. The signed LOI marks a clear commitment from both parties to negotiate a global distribution and joint product development agreement.As previously communicated, a commercial partnership with one of the market leaders with a matching product portfolio and well-established sales channels has been an integral part of Monivent’s strategy for a successful global

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 183 – 23 AUGUST 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 171/24 and 173/24, respectively. Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Martin Badsted, Chief Financial Officer, tel.: +45 33 42 05 26, e-mail: mba@norden.com

TORM plc capital increase in connection with exercise of Restricted Share Units as part of TORM’s incentive program

TORM plc has increased its share capital by 59,300 A-shares (corresponding to a nominal value of USD 593.0) as a result of the exercise of a corresponding number of Restricted Share Units.   All new shares are subscribed for in cash. 53,166 new shares are subscribed for at DKK 170.30 per A-share and 6,134 shares are subscribed for at 0.08 per A-share.   Transfer restrictions may apply in certain jurisdictions outside Denmark, including applicable US securities laws. The capital increase is carried out without any pre-emption rights for existing shareholders or others.

Report of transactions in TORM plc securities by directors and executive officers and their closely associated persons

TORM plc has been notified of the following transaction in TORM plc securities:   +---------------------------------------+--------+-------------------------+|Details of the reporting person / closely associated person |+---------------------------------------+--------+-------------------------+|Name |Jacob Balslev Meldgaard |+---------------------------------------+--------+-------------------------+|Reason for the notification |+---------------------------------------+-

Autoliv Declares Quarterly Dividend

(Stockholm, Sweden, August 23, 2024) – Autoliv, Inc. (NYSE: ALV and SSE: ALIV.sdb), the worldwide leader in automotive safety systems, today announced that its Board of Directors has declared a quarterly dividend of 68 cents for the third quarter of 2024.To holders of record on the close of business on Wednesday, September 4, the dividend will be payable on: · Monday, September 23, 2024 to holders of Autoliv common stock listed on the New York Stock Exchange (Common Stock); and · Tuesday, September 24, 2024 to holders of Autoliv Swedish Depository Receipts  listed on Nasdaq

Knox Energy Solutions AS – Company update

(Oslo, 23 August 2024) Following Knox Energy Solutions’ (Knox, OSE: KNOX) offer to Rapid Oil shareholders, a total of 17.5% of Rapid Oil shares have been accepted for conversion, of which 10% is conditional to continued listing. For further information, please contact:     Geir Aune, Chairman, ga@knox-energy.com    Harald B. Hansen, CEO, hh@knox-energy.com     About Knox | knox-energy.com   Knox Energy Solutions AS is an international energy company, with a holding in Rapid Oil Production Ltd. (Rapid), a UK-based oil and gas company backed by a highly experienced board and

LKAB applies for three strategic projects in the EU for mining and upgrading rare earth metals

LKAB is now applying to make the iron ore mine in Gällivare, the planned industrial site in Luleå, where LKAB will separate phosphorus and rare earth metals, and the large deposit of rare earth metals in Kiruna strategic projects in line with the EU's Critical Raw Material Act.The aim of the EU's Critical Raw Material Act is to secure Europe's supply of critical minerals via increased production within the EU as well as through diversified supply chains. Underlying this, among other factors, are the geopolitical situation and a dramatic increase in demand for certain minerals, not least to

CLS publishes half-year report January – June 2024

Summary of the half-year report (relates to the Group) First semester (01/01/2024–06/30/2024)  · Net sales totaled SEK 8,762,000 (SEK 1,839,000). · Profit/loss after financial items totaled SEK -26,163,000 (SEK -37,980,000). · Basic and diluted earnings per share totaled SEK -0.02 (SEK -0.25). · The equity ratio on June 30, 2024, was 63% (-31%).  The second quarter (04/01/2024–06/30/2024)  · Net sales totaled SEK 5,622,000 (SEK 1,252,000). · Profit/loss after financial items totaled SEK -13,592,000 (SEK -16,516,000). · Basic and diluted earnings per share

Brain+ fully on track towards market entry and first sales in the United Kingdom in H2 2024

NEWS RELEASE  Copenhagen, Denmark, 23 August 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · Brain+ is executing in full alignment with its Market Access plan for the CST-Assistant in the United Kingdom (UK), having met several milestones to date in 2024    · Additional UK-related key milestones in view for Q3 include validation of the Clinical Evaluation Report for the CST-Assistant, final results from the Age UK usability study, and full UK Medical Device certification   · Brain+ retains its expectations of the release of the CST-Assistant as a UK Medical-Device-Software

Carbiotix completes metformin study and provides EU funding update

Carbiotix (publ) ("Carbiotix" or the "Company") announces today that the metformin study has now been completed after aligning with the project group. While the Polymerase Chain Reaction (PCR) results communicated on November 1st, 2023, indicated that 20% of patients in the intervention cohort responded positively to a prebiotic containing CarbiAXOS, experiencing an average improvement of 15% in HbA1c (blood glucose) levels and an upregulation of Short Chain Fatty Acid (SCFA) levels, the Next Generation Sequencing (NGS) results after bioinformatic analysis were inconclusive due to the study’s

Ellos Group (publ) interim report January - June 2024

Press release, Borås, 23 August 2024The interim report for Ellos Group AB (publ) is published today.THE SECOND QUARTER 2024• Net sales decreased by 1.9 % to SEK 786,8 (802.1) million. Organically, net sales decreased by 1.9 %.• The gross margin decreased to 41.3 (42.6) %. The adjusted gross margin increased to 50.3 (42.6) %.• Adjusted EBITA increased to SEK 50.3 (41.3) million. The adjusted EBITA margin increased to 6.4 (5.2) %.• The operating profit/loss decreased to SEK -5.2 (13.8) million. The operating margin decreased to -0.7 (1.7) %.• Cash flow from operating activities

Half year Report January - June 2024

April – June 2024- Revenue MSEK 167 (133)- Order intake and Procurement Awards MSEK 418 (306)- Operating profit (EBITDA) MSEK 24.6 (19.2)- Operating profit (EBIT) MSEK 13.6 (5.6)- Total Comprehensive income MSEK 3.5 (27.9)- Earnings per share, before and after dilution (SEK) 0.83 (0.32)- Cash flow from operating activities MSEK -44.1 (-19.3) January – June 2024- Revenue MSEK 292 (246)- Order intake and Procurement Awards MSEK 736 (396)- Operating profit (EBITDA) MSEK 28.3 (20.7)- Operating profit (EBIT) MSEK 6.7 (-3.0)- Total Comprehensive income MSEK 23.2 (14.4)-

Invitation to presentation of Sectra’s three-month interim report 2024/2025

Linköping, Sweden – August 23, 2024 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) invites investors, analysts, and the media to a presentation of the company’s three-month report with President Torbjörn Kronander and CFO Jessica Holmquist.Publication of the financial report: 8:15 a.m. (CEST) on September 6, 2024Report presentation: 10:00 a.m. (CEST) on the same date To participate, follow the instructions on Sectra’s website investor.sectra.com/q1report2425.  The broadcast will be made available on the same webpage after the

Rejlers enters into collaboration with Stella Futura to strengthen the energy storage solutions of the future

Rejlers has signed a new cooperation agreement with Stella Futura, a leading company in technical and financial solutions for energy storage. Through this collaboration, Rejlers is strengthening its efforts to develop and optimise the use of battery storage facilities to support both current and future electricity grids.Rejlers offers expert services throughout the energy supply chain, from production and distribution to consumption, and offers services such as feasibility studies, grid investigations, design, analyses and investigations related to energy storage. Stella Futura offers its

Crunchfish publishes half-year report for 2024

Today, Crunchfish AB (“Crunchfish”) publishes the company’s half-year report for the second quarter and the first six months of 2024. Below is a brief summary of the report.+----------------------------------+----------+----------+-----------+-----------+|Group Financials |2024-04-01|2023-04-01|2024-01-01 |2023-01-01 || |2024-06-30|2023-06-30|2024-06-30 |2023-06-30 |+----------------------------------+----------+----------+-----------+-----------+|Net sales (SEK) |431 893 |294 731 |2 097 231 |465 303 |+----

Heliospectra (publ) Publish the Half-Year Report for Jan-Jun 2024

(GOTHENBURG, Sweden, Aug 23, 2024, at 08:30 CEST) – Heliospectra AB (publ), a leader in intelligent lighting technology for greenhouse and controlled plant growth environments, presents its Half-Year Report for the period January to June 2024.The full report is enclosed in this press release and uploaded at https://heliospectra.com/investor-relations/financial-reports-documents/reports/. SUMMARY OF REPORT Sales and financial performance April – June 2024 · Order intake during the period amounted to SEK 8,076 (9,503) thousand. · Net sales during the period amounted to SEK 4,402

HUMBLE GROUP PRESENTS NEW FINANCIAL TARGETS

The Board of Directors of Humble Group AB ("Humble" or the "Company") has today decided to adopt new financial targets. This decision is based on the structural development the Company has undergone since the previous targets were communicated on December 1, 2021. The new targets aim to reflect the Company's current objectives regarding growth and profitability, as well as to align with the Company's medium-term business plan. The targets and the Company's strategy will be presented at the Company's Capital Markets Day on September 19, 2024, in Stockholm.New Medium-Term Financial Targets:

Lytix Biopharma: Invitation to Q2 2024 Results Presentation

Lytix Biopharma AS (Euronext Growth Oslo: LYTIX), a leading Norwegian immuno-oncology company, will release its second quarter 2024 financial results on Thursday, 29 August 2024. Date: Thursday, 29 August 2024Time: 10:00 AM CET Join us for a live webcast presentation featuring CEO Øystein Rekdal and CFO Gjest Breistein, where they will discuss the results and provide key insights. Q&A Session:We welcome your questions in advance. Please send them to post@lytixbiopharma.com, and they will be addressed during the Q&A session following the presentation. Webcast Details:The

No. 74, 2024 – Nordea Kredits drawings as per 1 October 2024

Nordea Kredit hereby announces drawings data for callable covered mortgage credit bonds (SDRO) as per 1 October 2024. The figures are published in order to comply with publication requirements in the transparency regulation 2017/1129/EU and the Danish Act on Capital Markets section 24.   Questions can be directed to Torben Jurlander phone +45 55 47 41 99.     Yours faithfully   Nordea Kredit Realkreditaktieselskab

Cell Impact Q2 2024: New customers and growing sales

The quarter was dominated by continued efforts related to new and established customer projects which led to increased sales.The Group’s net sales for the second quarter of 2024 amounted to SEK 23.8 million (17.2), up 38 percent year-on-year and 310 percent on the preceding quarter. “During the quarter, we continued our dedicated and cost-conscious efforts to advance our operations according to plan, and we are currently heavily booked with various types of customer projects,” said Daniel Vallin, interim CEO. Cell Impact continued to strengthen its collaboration with F.C.C., and the

GomSpace Q2 2024 interim and half-year report

GomSpace shows positive free cashflow and significant increase in order intake in its Q2 2024 interim report. The guidance for positive free cashflow in 2[nd] half of 2024 is maintained. The company is expecting to surpass the revenue from 2023 for the full year of 2024.SECOND QUARTER OF 2024 •                     Order intake increased by 779% to T.SEK 199,233 (22,671) •                     Revenue increased by 31% to T.SEK 65,935 (50,275) •                     The gross margin significantly improved to 38% (-30%) •                     Operating profit (EBIT) improved to

Gradientech receives patent rights in Japan

The diagnostics company Gradientech reports having received a Notice of Allowance in Japan for its QuickMIC® cassette, the single-use test device in the QuickMIC® diagnostic system for ultra-rapid antibiotic susceptibility testing (AST).Gradientech announces that the Japan Patent Office has recognised the originality of the QuickMIC® cassette construction to be used in automated systems for antibiotic susceptibility testing of microorganisms. The Japanese patent application is based on the International Publication Number WO 2020/204799 and describes the design and functionality of a test

There are no items matching the current filter
There are no more items matching the current filter
Back to top